Cargando…

Hypertension and Antiangiogenesis: The Janus Face of VEGF Inhibitors

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Touyz, Rhian M., Lang, Ninian N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352216/ https://www.ncbi.nlm.nih.gov/pubmed/34396160 http://dx.doi.org/10.1016/j.jaccao.2019.08.010

Ejemplares similares

The Janus Face of VEGF in Stroke
por: Geiseler, Samuel J., et al.
Publicado: (2018)

Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events
por: Touyz, Rhian M., et al.
Publicado: (2018)

Mechanistic science in cardiovascular-oncology: the way forward to maximise anti-cancer drug effects and minimise cardiovascular toxicity
por: Lang, Ninian N., et al.
Publicado: (2021)

Cardiotoxic effects of angiogenesis inhibitors
por: Dobbin, Stephen J.H., et al.
Publicado: (2021)

Role of PARP and TRPM2 in VEGF Inhibitor‐Induced Vascular Dysfunction
por: Neves, Karla B., et al.
Publicado: (2023)

Vascular Complications of Cancer Chemotherapy
por: Cameron, Alan C., et al.
Publicado: (2016)

Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF
por: Im, S-A, et al.
Publicado: (2001)

Isolated Pulmonary Arterial Hypertension-Janus' Faces of Hyperthyroidism
por: Kang, Beodeul, et al.
Publicado: (2009)

Reply: Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting System
por: Cameron, Alan C., et al.
Publicado: (2021)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

The Two Faces of Janus
Publicado: (1993)

Janus-faced probability
por: Rocchi, Paolo
Publicado: (2014)

Acute vascular effects of vascular endothelial growth factor inhibition in the forearm arterial circulation
por: Cameron, Alan C., et al.
Publicado: (2020)

Monitoring antiangiogenesis of bevacizumab in zebrafish
por: Zhang, Jing, et al.
Publicado: (2018)

The Janus face of uranium in toxicology
por: Bolt, Hermann M.
Publicado: (2022)

Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review
por: Elyan, Benjamin M.P., et al.
Publicado: (2023)

A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes
por: Lees, Jennifer S, et al.
Publicado: (2022)

Vandetanib (ZD6474) induces antiangiogenesis through mTOR–HIF-1 alpha–VEGF signaling axis in breast cancer cells
por: Li, Ling, et al.
Publicado: (2018)

Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer
por: Lu, Heming, et al.
Publicado: (2022)

The Janus face of Darwinian competition
por: Hintze, Arend, et al.
Publicado: (2015)

The “Janus Face” of Platelets in Cancer
por: Catani, Maria Valeria, et al.
Publicado: (2020)

The Janus faces of thyroid carcinoma
Publicado: (2018)

Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy
por: Chen, Yijie, et al.
Publicado: (2015)

The Janus face of DNA methylation in aging
por: Mugatroyd, Chris, et al.
Publicado: (2010)

Surrogate markers in antiangiogenesis clinical trials
por: Davis, D W, et al.
Publicado: (2003)

Antiangiogenesis in recurrent glioblastoma: proof of principle
por: Nossek, Erez, et al.
Publicado: (2009)

Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
por: Wan, Xueting, et al.
Publicado: (2021)

Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo
por: Klenke, Frank M, et al.
Publicado: (2007)

Lower is better in hypertension, but how low should blood pressure be targeted?
por: Touyz, Rhian M.
Publicado: (2016)

Janus-faced role of SIRT1 in tumorigenesis
por: Song, Na-Young, et al.
Publicado: (2012)

Janus-faced taurine: protection or toxicity?
por: Taranukhin, Andrey, et al.
Publicado: (2015)

Stardust, the Janus-faced partner of Crumbs
por: Das, Shradha, et al.
Publicado: (2017)

Two Faced Janus of Quantum Nonlocality
por: Khrennikov, Andrei
Publicado: (2020)

Diabetes and dementia – the two faces of Janus
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2020)

BRAF: A Two-Faced Janus
por: Pisapia, Pasquale, et al.
Publicado: (2020)

“The Janus Face” of Thrombocytes in COVID-19
por: SINGH, SUHAIL, et al.
Publicado: (2021)

Janus-faced citrate in aging and metabolism
por: Lin, Wei-Sheng, et al.
Publicado: (2022)

Antiangiogenesis therapy: an update after the first decade
por: De Falco, Sandro
Publicado: (2014)

Clinical Trials of Antiangiogenesis Therapy on Gastric Cancer
por: Wu, Li Cun, et al.
Publicado: (2008)

Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer()
por: Ribatti, Domenico, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nmfl5tau3tps2qi0csm27vgl7b